Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2009-3-2
pubmed:abstractText
Resistance to STI571 is an emerging problem for patients with chronic myelogenous leukemia (CML). Mutation in the kinase domain of Bcr-Abl is the predominant mechanism of the acquired resistance to STI571. In the present study, we investigated the effect of triptolide on cell survival or apoptosis in CML cells bearing Bcr-Abl-T315I or wild-type Bcr-Abl.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Alkylating, http://linkedlifedata.com/resource/pubmed/chemical/Diterpenes, http://linkedlifedata.com/resource/pubmed/chemical/Epoxy Compounds, http://linkedlifedata.com/resource/pubmed/chemical/Fusion Proteins, bcr-abl, http://linkedlifedata.com/resource/pubmed/chemical/Phenanthrenes, http://linkedlifedata.com/resource/pubmed/chemical/Piperazines, http://linkedlifedata.com/resource/pubmed/chemical/Protein Kinase Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Protein-Tyrosine Kinases, http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-akt, http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-bcl-2, http://linkedlifedata.com/resource/pubmed/chemical/Pyrimidines, http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger, http://linkedlifedata.com/resource/pubmed/chemical/Reactive Oxygen Species, http://linkedlifedata.com/resource/pubmed/chemical/imatinib, http://linkedlifedata.com/resource/pubmed/chemical/myeloid cell leukemia sequence 1..., http://linkedlifedata.com/resource/pubmed/chemical/triptolide
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1078-0432
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
15
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1686-97
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:19240172-Adolescent, pubmed-meshheading:19240172-Adult, pubmed-meshheading:19240172-Aged, pubmed-meshheading:19240172-Animals, pubmed-meshheading:19240172-Antineoplastic Agents, Alkylating, pubmed-meshheading:19240172-Apoptosis, pubmed-meshheading:19240172-Blotting, Western, pubmed-meshheading:19240172-Cell Cycle, pubmed-meshheading:19240172-Cell Proliferation, pubmed-meshheading:19240172-Diterpenes, pubmed-meshheading:19240172-Drug Resistance, Neoplasm, pubmed-meshheading:19240172-Epoxy Compounds, pubmed-meshheading:19240172-Female, pubmed-meshheading:19240172-Flow Cytometry, pubmed-meshheading:19240172-Fusion Proteins, bcr-abl, pubmed-meshheading:19240172-Humans, pubmed-meshheading:19240172-Immunoenzyme Techniques, pubmed-meshheading:19240172-Leukemia, Myelogenous, Chronic, BCR-ABL Positive, pubmed-meshheading:19240172-Male, pubmed-meshheading:19240172-Membrane Potential, Mitochondrial, pubmed-meshheading:19240172-Mice, pubmed-meshheading:19240172-Mice, Inbred BALB C, pubmed-meshheading:19240172-Mice, Nude, pubmed-meshheading:19240172-Middle Aged, pubmed-meshheading:19240172-Mutation, pubmed-meshheading:19240172-Phenanthrenes, pubmed-meshheading:19240172-Piperazines, pubmed-meshheading:19240172-Protein Kinase Inhibitors, pubmed-meshheading:19240172-Protein-Tyrosine Kinases, pubmed-meshheading:19240172-Proto-Oncogene Proteins c-akt, pubmed-meshheading:19240172-Proto-Oncogene Proteins c-bcl-2, pubmed-meshheading:19240172-Pyrimidines, pubmed-meshheading:19240172-RNA, Messenger, pubmed-meshheading:19240172-Reactive Oxygen Species, pubmed-meshheading:19240172-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:19240172-Signal Transduction, pubmed-meshheading:19240172-Transcription, Genetic, pubmed-meshheading:19240172-Tripterygium, pubmed-meshheading:19240172-Tumor Cells, Cultured, pubmed-meshheading:19240172-Tumor Stem Cell Assay, pubmed-meshheading:19240172-Xenograft Model Antitumor Assays, pubmed-meshheading:19240172-Young Adult
pubmed:year
2009
pubmed:articleTitle
Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation.
pubmed:affiliation
Department of Pathophysiology, Zhongshan School of Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't